Do not treat medication interactions as internet trivia
Medication interaction questions are where psilocybin harm reduction needs to become very practical. If you take psychiatric medication, heart medication, seizure medication, lithium, stimulants, opioids, benzodiazepines, sleep medications, migraine drugs, supplements, or multiple substances, you need more than a forum answer.
This checklist is educational only. It is not medical advice, and it is not a tapering plan. Do not stop or change prescription medication to prepare for psilocybin without the prescriber who knows your history.
Use this with LearnShrooms' drug interaction guide, SSRI washout guide, contraindications guide, and provider verification checklist.
The first rule: disclose the full list
A provider cannot screen what they do not know. Bring the full list:
- prescription medications
- over-the-counter medications
- supplements
- hormones
- cannabis
- alcohol
- stimulants
- opioids
- benzodiazepines
- sleep aids
- migraine medications
- herbs such as St. John's wort
- previous medication tapers that caused problems
Include dose, schedule, last dose, and why you take each one. If you are tempted to hide a medication because you fear being declined, that is a sign to slow down. Screening out is not punishment. It can be the safest clinical decision.
Interactions that deserve special caution
Lithium
Lithium is one of the clearest red-flag medications in psychedelic harm-reduction literature. Case reports and online-case analyses have associated lithium plus classic psychedelics with seizures and severe adverse reactions. Oregon's client information form specifically asks whether a client is taking lithium.
Do not combine lithium and psilocybin based on internet reassurance.
MAOIs and serotonergic stacking
Prescription monoamine oxidase inhibitors are uncommon but still used for some treatment-resistant depression cases. Some plants and supplements also have MAOI-like activity. Combining serotonergic substances can increase medical complexity, including concern for serotonin toxicity in some combinations. This is a prescriber-level question, not a self-experiment.
SSRIs and SNRIs
SSRIs and SNRIs may blunt or change the psychedelic response. Some clinical trials require tapering or washout, but tapering itself can destabilize mood, sleep, anxiety, and suicidality. If a provider's only advice is "just stop your meds for two weeks," that is not enough.
The right question is not only "Will it work?" It is "What is the medical risk of changing a medication that currently keeps me stable?"
Antipsychotics and bipolar medications
Antipsychotics, mood stabilizers, and medications used for bipolar disorder or psychotic disorders need careful review. Psilocybin can intensify perception, emotion, sleep disruption, and meaning-making. People with a personal or family history of psychosis or mania are often excluded from clinical trials for good reasons.
Benzodiazepines, opioids, alcohol, and sedatives
Some sedatives may blunt anxiety or intensity, but they also add risks around memory, breathing, falls, dependence, withdrawal, and impaired consent. Alcohol can worsen judgment, nausea, dehydration, emotional volatility, and post-session risk. A session plan should include sober transportation and avoid casual substance stacking.
Stimulants and cardiovascular drugs
Psilocybin can raise blood pressure and heart rate during acute effects. Stimulants, some ADHD medications, decongestants, and cardiovascular conditions can make this more important. If you have uncontrolled hypertension, arrhythmia, chest pain, fainting history, or complex heart disease, get medical guidance first.
The Oregon screening model is a useful baseline
Oregon's client information form asks about prescriptions, supplements, lithium, allergies, traumatic experiences, medical treatment, mental health treatment, substance use, and support needs. That is the level of detail readers should expect from a serious provider.
If your provider does not ask medication questions before payment or dosing, that is a safety problem.
Questions for your prescriber
You do not need to ask your prescriber to endorse psilocybin. You can ask safety questions:
- Is it medically risky for me to stop or taper this medication?
- Have I had discontinuation symptoms before?
- What symptoms should make me restart, pause, or seek urgent care?
- Does my diagnosis include mania, psychosis, seizure risk, or suicidality that changes this decision?
- Are any of my medications dangerous to combine with serotonergic substances?
- What would a safe monitoring plan look like if I pursue this anyway?
If a prescriber is unfamiliar with psilocybin, ask them to focus on medication stability, taper risk, and contraindications.
What a provider should say
A good provider will not promise that every medication is fine. A good provider will:
- ask for the medication list early
- refer medical questions to an appropriate clinician
- document safety concerns
- decline or postpone when needed
- avoid coaching people to hide medication use
- distinguish blunting from danger
- have a plan for panic, insomnia, mania, suicidality, or medical symptoms after the session
Emergency signs after any psychedelic use
Seek urgent help if there is chest pain, seizure, very high fever, severe confusion, dangerous agitation, inability to stay hydrated, suicidal intent, psychosis, mania, or symptoms that feel medically serious. Call emergency services when safety is at risk. Use 988 crisis resources for suicide or mental health crisis support.
Bottom line
Medication interaction work is not about moral purity or gatekeeping. It is about protecting people whose nervous systems are already carrying complexity. If medication stability took years to build, do not dismantle it for a session without clinical support.